CN112544712A - Lentinan soluble bean for improving intestinal immunity of children by diet and preparation method thereof - Google Patents
Lentinan soluble bean for improving intestinal immunity of children by diet and preparation method thereof Download PDFInfo
- Publication number
- CN112544712A CN112544712A CN202011392950.5A CN202011392950A CN112544712A CN 112544712 A CN112544712 A CN 112544712A CN 202011392950 A CN202011392950 A CN 202011392950A CN 112544712 A CN112544712 A CN 112544712A
- Authority
- CN
- China
- Prior art keywords
- parts
- lentinan
- organic
- powder
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001491 Lentinan Polymers 0.000 title claims abstract description 120
- 229940115286 lentinan Drugs 0.000 title claims abstract description 120
- 244000046052 Phaseolus vulgaris Species 0.000 title claims abstract description 59
- 235000010627 Phaseolus vulgaris Nutrition 0.000 title claims abstract description 59
- 230000008944 intestinal immunity Effects 0.000 title claims abstract description 23
- 235000005911 diet Nutrition 0.000 title claims abstract description 19
- 230000037213 diet Effects 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 117
- 239000002131 composite material Substances 0.000 claims abstract description 47
- 229930003231 vitamin Natural products 0.000 claims abstract description 34
- 235000013343 vitamin Nutrition 0.000 claims abstract description 34
- 239000011782 vitamin Substances 0.000 claims abstract description 34
- 229940088594 vitamin Drugs 0.000 claims abstract description 34
- 239000006041 probiotic Substances 0.000 claims abstract description 33
- 235000018291 probiotics Nutrition 0.000 claims abstract description 33
- 238000000855 fermentation Methods 0.000 claims abstract description 29
- 230000004151 fermentation Effects 0.000 claims abstract description 29
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 28
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229920002472 Starch Polymers 0.000 claims abstract description 27
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 27
- 235000013618 yogurt Nutrition 0.000 claims abstract description 25
- 235000021432 organic honey Nutrition 0.000 claims abstract description 24
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 23
- 239000005862 Whey Substances 0.000 claims abstract description 22
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 22
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 22
- 210000002969 egg yolk Anatomy 0.000 claims abstract description 22
- 235000019698 starch Nutrition 0.000 claims abstract description 18
- 239000008107 starch Substances 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 11
- 239000000243 solution Substances 0.000 claims description 60
- 238000007710 freezing Methods 0.000 claims description 30
- 230000008014 freezing Effects 0.000 claims description 30
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000012043 crude product Substances 0.000 claims description 20
- 238000001914 filtration Methods 0.000 claims description 19
- 230000001954 sterilising effect Effects 0.000 claims description 19
- 239000000706 filtrate Substances 0.000 claims description 18
- 238000010438 heat treatment Methods 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 18
- 235000013339 cereals Nutrition 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 17
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 16
- 238000005303 weighing Methods 0.000 claims description 16
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 14
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 13
- 108010059892 Cellulase Proteins 0.000 claims description 13
- 108090000526 Papain Proteins 0.000 claims description 13
- 239000004365 Protease Substances 0.000 claims description 13
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 13
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 13
- 229940106157 cellulase Drugs 0.000 claims description 13
- -1 compound vitamin Chemical class 0.000 claims description 13
- 229940055729 papain Drugs 0.000 claims description 13
- 235000019834 papain Nutrition 0.000 claims description 13
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 12
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 12
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 12
- 229930003268 Vitamin C Natural products 0.000 claims description 12
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 12
- 238000004108 freeze drying Methods 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 238000000465 moulding Methods 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 12
- 238000004659 sterilization and disinfection Methods 0.000 claims description 12
- 235000019155 vitamin A Nutrition 0.000 claims description 12
- 239000011719 vitamin A Substances 0.000 claims description 12
- 235000019154 vitamin C Nutrition 0.000 claims description 12
- 239000011718 vitamin C Substances 0.000 claims description 12
- 229940045997 vitamin a Drugs 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 11
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 11
- 229940041514 candida albicans extract Drugs 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 11
- 238000000227 grinding Methods 0.000 claims description 11
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 11
- 239000012138 yeast extract Substances 0.000 claims description 11
- 102000002322 Egg Proteins Human genes 0.000 claims description 10
- 108010000912 Egg Proteins Proteins 0.000 claims description 10
- 235000013345 egg yolk Nutrition 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- BTFBEYFQMPGYLB-UHFFFAOYSA-N butane-1,4-diol;hydrochloride Chemical compound Cl.OCCCCO BTFBEYFQMPGYLB-UHFFFAOYSA-N 0.000 claims description 9
- 229960001231 choline Drugs 0.000 claims description 9
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- 230000005496 eutectics Effects 0.000 claims description 9
- 229940100445 wheat starch Drugs 0.000 claims description 9
- 235000013305 food Nutrition 0.000 claims description 8
- 235000014655 lactic acid Nutrition 0.000 claims description 8
- 239000004310 lactic acid Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 7
- 235000019743 Choline chloride Nutrition 0.000 claims description 7
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 7
- 229960003178 choline chloride Drugs 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- 238000011081 inoculation Methods 0.000 claims description 6
- 238000001471 micro-filtration Methods 0.000 claims description 6
- 239000002244 precipitate Substances 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 239000011265 semifinished product Substances 0.000 claims description 6
- 239000012265 solid product Substances 0.000 claims description 6
- 229910001220 stainless steel Inorganic materials 0.000 claims description 6
- 239000010935 stainless steel Substances 0.000 claims description 6
- 230000006872 improvement Effects 0.000 claims description 5
- 239000004570 mortar (masonry) Substances 0.000 claims description 5
- 229910052755 nonmetal Inorganic materials 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 5
- 240000000599 Lentinula edodes Species 0.000 claims description 4
- 235000001715 Lentinula edodes Nutrition 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 241000186660 Lactobacillus Species 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 3
- 229940039696 lactobacillus Drugs 0.000 claims description 3
- 238000000643 oven drying Methods 0.000 claims description 3
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 2
- 240000009088 Fragaria x ananassa Species 0.000 claims description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 2
- 229940100486 rice starch Drugs 0.000 claims description 2
- 230000000378 dietary effect Effects 0.000 claims 4
- 230000000694 effects Effects 0.000 abstract description 21
- 239000000126 substance Substances 0.000 abstract description 9
- 230000036541 health Effects 0.000 abstract description 4
- 235000019640 taste Nutrition 0.000 abstract description 3
- 235000013348 organic food Nutrition 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 25
- 230000036039 immunity Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 210000001035 gastrointestinal tract Anatomy 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 108010019160 Pancreatin Proteins 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 210000002540 macrophage Anatomy 0.000 description 4
- 229940055695 pancreatin Drugs 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 229920001503 Glucan Polymers 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 210000000822 natural killer cell Anatomy 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229940118019 malondialdehyde Drugs 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 1
- 240000007440 Agaricus campestris Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 210000001239 CD8-positive, alpha-beta cytotoxic T lymphocyte Anatomy 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241001076416 Dendrobium tosaense Species 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
- 108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
- 102000008072 Lymphokines Human genes 0.000 description 1
- 108010074338 Lymphokines Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010047141 Vasodilatation Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 208000029560 autism spectrum disease Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000037208 balanced nutrition Effects 0.000 description 1
- 235000019046 balanced nutrition Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000001516 cell proliferation assay Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 230000006054 immunological memory Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 201000005249 lung adenocarcinoma Diseases 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 108010010998 polyactin A Proteins 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 238000011870 unpaired t-test Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/127—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1315—Non-milk proteins or fats; Seeds, pulses, cereals or soja; Fatty acids, phospholipids, mono- or diglycerides or derivatives therefrom; Egg products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/123—Bulgaricus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a lentinan soluble bean for improving intestinal immunity of children through diet and a preparation method thereof, wherein the raw materials comprise, by weight, 10-40 parts of an organic lentinan solution, 5-10 parts of trehalose, 100 parts of skimmed milk powder, 10-20 parts of whey powder, 25-30 parts of grain starch, 10-50 parts of yolk powder, 1-5 parts of fermentation powder, 1-5 parts of composite probiotics, 0.5-1 part of composite vitamins and 5-10 parts of organic honey. The invention adopts the organic mushroom to prepare the yoghourt dissolving bean for the first time. The organic food has less chemical substance residue, less pollution, good taste, health promotion effect, and no other side effects, and is suitable for children.
Description
Technical Field
The invention relates to the field of child complementary food processing, in particular to lentinan soluble beans for improving intestinal immunity of children through diet and a preparation method thereof.
Background
Balanced nutrition is a prerequisite to ensure healthy growth of children. In the infant birth period, breast milk is the most ideal source of nutrient intake for babies. However, as a child grows, additional nutritional supplements should be provided in addition to breast milk to meet the many nutrients the child needs for growth.
Most of germs are taken from the oral cavity, and the main way for pathogens such as bacteria to enter each organ of a human body is the intestinal tract, so that the immunity of the intestinal tract is very important for the health of the human body. The intestinal tract is the largest immune organ of a human body, the lymphoid tissue accounts for 25-40% of the whole intestinal tract tissue, and about 70% of immune cells of the human body are gathered in the intestinal tract, so that the intestinal tract has important effects of resisting invading pathogens, generating immunological memory and the like. Children, especially infants aged 2-10 years, have poor barrier function due to imperfect intestinal structure and loose structure, and are prone to leak allergens and pathogenic bacteria, which cause damage to multiple organs including the brain through blood circulation, thereby causing various developmental diseases of children, including autism spectrum disorder, hyperactivity disorder, hypointelligence, etc. In addition, the normal flora in the intestinal cavity of the infant is not completely established, acquired immunity to pathogens is not formed, and the intestinal immunity function is insufficient, so that the acquisition of the nutrient components for enhancing the immunity from food is very important.
Compared with common mushrooms, the organic mushrooms are greener and more natural in culture environment, no chemical substance residues such as pesticides are left, and the nutritional value is higher. The organic lentinan is an effective active ingredient extracted from high-quality organic lentinus edodes fruiting bodies. The glucan is a glucan, the main chain is composed of beta- (1 → 3) -connected glucosyl, and the glucosyl connected with the beta- (1 → 6) is randomly distributed along the main chain and is in a comb-shaped structure. Lentinan, which was first used in the medical field, is an immunomodulator that prevents tumorigenicity caused by chemical factors, inhibits tumor metastasis, enhances the body's resistance to various bacteria, viruses and parasites, and has hardly any side effects. Modern researches show that the main components of lentinan comprise mannitol, trehalose, mycose, glucose, pentosan, methyl pentosan and the like. The saccharides are involved in regulating the immune function and the activity of T lymphocytes of human bodies, can reduce the capacity of the methyl compounds to induce tumors, and mainly have the following four functions:
immune regulation: by stimulating the maturation, differentiation and proliferation of key immune cells (T, B lymphocytes, macrophages, NK cells, etc.), the host somatic balance is improved, and the reactivity of host cells to lymphokines, hormones and other bioactive factors is restored or improved.
② anti-tumor effect: the anti-tumor effect is achieved by enhancing and inducing activated macrophages and killer T cells, improving NK cell activity and enhancing antibody-dependent macrophage toxicity by a host.
③ antiviral action: activating in vivo macrophage, increasing CD4+ cell and IL-2 receptor expression, inducing IFN (interferon), and increasing NK cell activity.
Fourthly, anti-infection function: free sugar molecules in body fluid are combined with virus to play a role in shielding and prevent pathogens from adhering to sugar molecules on the surface of normal cells.
At present, lentinan is mainly applied to the field of health-care food, namely lentinan capsules (Chinese medicine standard character Z20080579), the main components of the lentinan capsules are polysaccharides such as glucan, mannatide and the like and various amino acids, and the lentinan capsules have the effects of activating cellular immunity, regulating various humoral immune factors, inducing the generation of alpha-interferon, regulating immune response of organisms, inducing leukocyte infiltration on tumors, causing vasodilatation, bleeding and necrosis of tumor parts, preventing the combination of viruses and host cells, improving the activity of superoxide dismutase (SOD), inhibiting the generation of Malondialdehyde (MDA), resisting lipid oxidation, reducing blood fat, regulating carbohydrate metabolism, improving carbohydrate tolerance, expanding gastrointestinal tracts to generate satiety, reducing appetite, reducing blood sugar and the like. In addition, there is also a report of adding lentinan to prepare a medicine and food dual purpose Chinese medicinal composition. For example, the patent of 'a Chinese medicinal composition for improving human body immunity and a preparation method thereof used as both medicine and food' with the application number of 202010408216.7 mainly aims at providing a Chinese medicinal composition which is safe to eat and is used for enhancing the postoperative immunity of tumor patients. The raw materials of the traditional Chinese medicine composition contain more traditional Chinese medicine components, such as dendrobium officinale, green tea and the like, so the traditional Chinese medicine composition is not suitable for developing children. At present, the soybean dissolving product which is added with organic lentinan to be prepared into a favorite soybean dissolving product for children and can enhance the immunity is only reported.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provides a lentinan dissolved bean for improving the intestinal immunity of children by diet and a preparation method thereof. The soluble bean has good taste, slightly sour and sweet taste, easy digestion, convenient service, and good health promotion effect.
In order to achieve the purpose, the lentinan soluble bean for improving the intestinal immunity of children through diet comprises, by weight, 10-40 parts of an organic lentinan solution, 5-10 parts of trehalose, 100 parts of skim milk powder, 10-20 parts of whey powder, 25-30 parts of grain starch, 10-50 parts of yolk powder, 1-5 parts of fermentation powder, 1-5 parts of composite probiotics, 0.5-1 part of composite vitamins and 5-10 parts of organic honey.
Furthermore, the raw materials of the compound mushroom health-care food comprise, by weight, 20-30 parts of an organic lentinan solution, 6-9 parts of trehalose, 110 parts of skimmed milk powder, 10-15 parts of whey powder, 25-30 parts of cereal starch, 20-40 parts of egg yolk powder, 1-3 parts of baking powder, 1-3 parts of compound probiotics, 0.5-1 part of compound vitamin and 5-8 parts of organic honey.
Still further, the cereal starch is wheat starch or rice starch;
the fermentation powder consists of lactic acid bacteria and yeast extract in a weight ratio of 1: 1-2.
Still further, the composite probiotics consist of lactobacillus bulgaricus, bifidobacterium lactis and streptococcus thermophilus; the weight ratio of the components is 1:100: 100;
the compound vitamin consists of vitamin A and vitamin C in the weight ratio of 1:20-600 (the raw materials are converted into effective substances by other varieties approved by GB 14880).
Furthermore, the raw materials of the milk powder comprise 30 parts of organic lentinan solution, 7 parts of trehalose, 120 parts of skimmed milk powder, 17 parts of whey powder, 27 parts of wheat starch, 30 parts of egg yolk powder, 3 parts of baking powder, 3 parts of composite probiotics, 0.7 part of composite vitamin and 8 parts of organic honey in parts by weight; the fermentation powder consists of lactic acid bacteria and yeast extract in a weight ratio of 1: 1; the composite probiotics comprise lactobacillus bulgaricus, bifidobacterium lactis and streptococcus thermophilus; the weight ratio of the components is 1:100: 100;
the compound vitamin consists of vitamin A and vitamin C according to the weight ratio of 1: 100.
Still further, the lentinan soluble bean has a shape selected from the group consisting of an acerose shape, a spherical shape and a strawberry shape
The invention also provides a preparation method of the lentinan soluble bean for improving the intestinal immunity of children by the diet, which comprises the following steps:
1) weighing the following components in parts by weight: 10-40 parts of organic lentinan solution, 5-10 parts of trehalose, 120 parts of skimmed milk powder, 10-20 parts of whey powder, 25-30 parts of cereal starch, 10-50 parts of yolk powder, 1-5 parts of fermentation powder, 1-5 parts of composite probiotics, 0.5-1 part of composite vitamins and 5-10 parts of organic honey;
2) dissolving: dissolving trehalose, skimmed milk powder, whey powder, grain starch, yolk powder and baking powder in sequence to obtain a mixed solution;
3) preheating: heating the mixed solution to 60-80 ℃ for preheating, and then filtering;
4) homogenizing: homogenizing the preheated filtrate;
5) and (3) sterilization: heating and sterilizing the homogenized filtrate at 90-95 deg.C for 5-10 min;
6) inoculation: after sterilization, cooling to 45 ℃, and adding fermentation powder;
7) fermentation: fermenting the inoculated semi-finished product at 40 deg.C for 10 hr. Taking out when the acidity reaches 70 ℃ T, placing the mixture into a heat-preservation container to 4 ℃, and refrigerating;
8) mixing and emulsifying: stirring and demulsifying fermented and aged yoghourt, adding the organic lentinan solution, the composite probiotics, the composite vitamins and the organic honey, and uniformly stirring for later use;
9) freezing: pouring the obtained uniform material into a freezing machine for freezing treatment to obtain a semi-solid product for molding;
10) quick freezing: pouring the frozen material into a mould, and quickly freezing and molding for 1-2h at the temperature of-80 ℃;
11) and (3) freeze drying: placing the frozen yogurt into a stainless steel plate one by one, placing the yogurt into a cabin of a freeze dryer, and freeze-drying to obtain dry solid soluble beans;
12) weighing the obtained dry solid dissolved beans, and subpackaging to obtain the organic lentinan dissolved beans.
Preferably, in the step 1),
the organic lentinan solution is prepared by the following steps:
a. preparing an organic lentinan crude product:
cleaning fruiting body of organic Lentinus Edodes which grows well and does not go moldy, cutting off root, dicing pileus, oven drying at 70-80 deg.C, grinding into powder, adding cellulase and papain for enzymolysis, adding choline chloride-1, 4-butanediol deep eutectic solvent for extraction, filtering, dialyzing the filtrate to remove impurities, adsorbing with microfiltration active carbon for decolorizing, and heating for concentration; finally adding ethanol, stirring, standing, centrifuging, and drying the obtained precipitate at 50-60 deg.C to obtain lentinan crude product;
b. preparing an organic lentinan solution:
c, adding water to the organic lentinan crude product obtained in the step a for uniform dissolution, and filtering to obtain an organic lentinan solution for later use;
the compound vitamin is prepared by the following steps:
weighing vitamin A and vitamin C (the raw materials are converted into effective substances by adopting other varieties approved by GB 14880) according to the weight ratio of 1:20-600, adding into a nonmetal mortar, uniformly grinding for 1-2 minutes, and sealing for later use.
The fermentation powder consists of lactobacillus and yeast extract in the weight ratio of 1 to 1-2.
The composite probiotics comprise lactobacillus bulgaricus, bifidobacterium lactis and streptococcus thermophilus; their weight ratio was 1:100: 100.
Preferably, in the step a,
the choline chloride-1, 4-butanediol deep eutectic solvent is formed by mixing choline chloride and 1, 4-butanediol, wherein the molar ratio of the choline chloride to the 1, 4-butanediol is 1: 4;
the enzymolysis conditions of the cellulase are as follows:
performing enzymolysis at 45 deg.C and pH of 4.6 for 45 min;
the enzymolysis conditions of the papain are as follows:
performing enzymolysis at 50 deg.C and pH of 6.1 for 30 min;
the concentration of cellulase is 0.5 wt% (aqueous solution), the concentration of papain is 1.5 wt% (aqueous solution);
the ethanol is 95% ethanol solution by volume concentration. Preferably, in the step b, 50mL of water is added into each 20-30g of the lentinan crude product.
The invention has the beneficial effects that:
1) the invention adopts the organic mushroom to prepare the yoghourt dissolving bean for the first time. The organic food has less chemical substance residue, less pollution, good taste, health promotion effect, and no other side effects, and is suitable for children.
2) According to the invention, the organic lentinan is added into the yoghourt dissolving bean product, so that various nutritional ingredients such as protein, lipid and mineral elements in the yoghourt dissolving bean are maintained, and various health-care functions such as antivirus, anticancer and human immunity improvement of the product are added.
3) The organic honey is added into the yoghourt dissolving bean. Compared with common honey, the organic honey is natural mature honey which comes from non-transgenic plants, has few food additives and high nutritive value, and is a healthy ingredient more suitable for children to eat.
4) The yoghurt-dissolving bean of the invention is also added with bifidobacterium lactis, streptococcus thermophilus, bulgaricus and compound vitamins, and has the effect of enhancing the intestinal immunity. The bifidobacterium lactis is an important physiological bacterium of a human body, has important functions on nutrition of milk and prevention of intestinal diseases, and participates in a series of physiological processes of immunity, nutrition, digestion, protection and the like of the human body. The streptococcus thermophilus and the bulgaricus have the effects of improving intestinal microenvironment, regulating blood pressure, resisting cancer, delaying aging and the like. Vitamin A is a coenzyme for regulating glycoprotein synthesis, has stabilizing effect on epithelial cell membrane, and can maintain the complete shape and function of epithelial cell. Vitamin C has antibody oxidation effect.
5) Trehalose is added into the yoghurt-dissolving bean to replace the traditional white granulated sugar, so that the yoghurt-dissolving bean not only has proper sweetness, but also can avoid protein denaturation, and also has a health-care function. Trehalose is a proliferation factor beneficial to intestinal bacteria, namely bifidobacterium, in vivo, can improve the intestinal micro-ecological environment, strengthen the digestive absorption function of the gastrointestinal tract, effectively eliminate vivotoxin and enhance the immunity and disease resistance of organisms, and researches prove that trehalose has stronger radiation resistance.
6) The method adopts a choline chloride-1, 4-butanediol deep eutectic solvent extraction method to replace the traditional water boiling method to extract the organic lentinan, and has higher extraction efficiency and good utilization rate of raw materials.
7) The invention utilizes the vacuum freeze drying technology, preserves the activity of effective active substances in the yogurt dissolving bean, prolongs the storage time of the product and improves the mouthfeel of the yogurt.
Drawings
FIG. 1 is a graph showing the effect of an organic lentinan solution on the survival rate of A549 cells affected by LPS;
FIG. 2 is a graph of cell growth in different treatment groups;
in the figure, FIG. 2A is a diagram showing the growth of cells under normal culture conditions,
FIG. 2B is a graph showing the growth of cells treated with LPS,
FIG. 2C is a graph showing the growth of cells treated with LPS and lentinan.
Detailed Description
The present invention is described in further detail below with reference to specific examples so as to be understood by those skilled in the art.
The lentinan soluble bean for improving the intestinal immunity of children through diet comprises, by weight, 10-40 parts of an organic lentinan solution, 5-10 parts of trehalose, 120 parts of skimmed milk powder, 10-20 parts of whey powder, 25-30 parts of grain starch, 10-50 parts of egg yolk powder, 1-5 parts of fermentation powder, 1-5 parts of composite probiotics, 0.5-1 part of composite vitamins and 5-10 parts of organic honey.
The preparation method of the lentinan soluble bean for improving the intestinal immunity of children by using the diet comprises the following steps:
1) weighing the following components in parts by weight: 10-40 parts of organic lentinan solution, 5-10 parts of trehalose, 120 parts of skimmed milk powder, 10-20 parts of whey powder, 25-30 parts of cereal starch, 10-50 parts of yolk powder, 1-5 parts of fermentation powder, 1-5 parts of composite probiotics, 0.5-1 part of composite vitamins and 5-10 parts of organic honey; the organic lentinan solution is prepared by the following steps:
a. preparing an organic lentinan crude product:
cleaning fruiting body of organic Lentinus Edodes which grows well and does not go moldy, cutting off root, dicing pileus, oven drying at 70-80 deg.C, grinding into powder, adding cellulase and papain for enzymolysis, adding choline chloride-1, 4-butanediol deep eutectic solvent for extraction, filtering, dialyzing the filtrate to remove impurities, adsorbing with microfiltration active carbon for decolorizing, and heating for concentration; finally adding ethanol, stirring, standing, centrifuging, and drying the obtained precipitate at 50-60 deg.C to obtain lentinan crude product;
b. preparing an organic lentinan solution:
c, adding water to the organic lentinan crude product obtained in the step a for uniform dissolution, and filtering to obtain an organic lentinan solution for later use;
2) dissolving: dissolving trehalose, skimmed milk powder, whey powder, grain starch, yolk powder and baking powder in sequence to obtain a mixed solution;
3) preheating: heating the mixed solution to 60-80 ℃ for preheating, and then filtering;
4) homogenizing: homogenizing the preheated filtrate;
5) and (3) sterilization: heating and sterilizing the homogenized filtrate at 90-95 deg.C for 5-10 min;
6) inoculation: after sterilization, cooling to 45 ℃, and adding fermentation powder;
7) fermentation: fermenting the inoculated semi-finished product at 40 deg.C for 10 hr. Taking out when the acidity reaches 70 ℃ T, placing the mixture into a heat-preservation container to 4 ℃, and refrigerating;
8) mixing and emulsifying: stirring and demulsifying fermented and aged yoghourt, adding the organic lentinan solution, the composite probiotics, the composite vitamins and the organic honey, and uniformly stirring for later use;
9) freezing: pouring the obtained uniform material into a freezing machine for freezing treatment to obtain a semi-solid product for molding;
10) quick freezing: pouring the frozen material into a mould, and quickly freezing and molding for 1-2h at the temperature of-80 ℃;
11) and (3) freeze drying: placing the frozen yogurt into a stainless steel plate one by one, placing the yogurt into a cabin of a freeze dryer, and freeze-drying to obtain dry solid soluble beans;
12) weighing the obtained dry solid dissolved beans, and subpackaging to obtain the organic lentinan dissolved beans.
MTT method based method for detecting influence of organic lentinan solution prepared by the method on survival rate of A549 cells induced by LPS
1. Material
1.1 test cells: a549 (human lung adenocarcinoma cell, Hubei university of industry, health and accurate medicine nutrition laboratory)
2. Medicinal material reagent
LPS (Biosharp, Cat. No. BS904), penicillin/streptomycin (Beyotime), fetal bovine serum (Sijiu), pancreatin (Gibio), DMEM minimal medium (Hyclone), PBS (Hyclone), and MTT cell proliferation and cytotoxicity assay kit (Solarbio, Cat. No. M1020). 2. Cell culture 1) cell recovery
Placing a cell cryopreservation tube stored at-80 ℃ in a 37 ℃ water bath pot for melting, transferring to a 1.5mL centrifuge tube, centrifuging at 1500 rpm for 5min, discarding the supernatant, washing with PBS for 2 times, adding 200 μ L of fresh cell culture solution, blowing, uniformly mixing, transferring to a culture dish, adding 6mL of fresh cell culture solution, and uniformly mixing; 37 ℃ and 5% CO2Culturing under the condition.
2) Cell passage
Collecting cells in logarithmic growth phase, discarding old culture medium, washing with 2mL PBS for 1 time, adding 1mL pancreatin, gently shaking culture dish to completely cover cells with pancreatin, discarding pancreatin, placing at 37 deg.C and 5% CO2Digesting for 3-5min, adding 2mL of fresh cell culture solution, gently pumping, mixing, transferring 500 μ L of the mixture into a culture dish containing 6mL of fresh cell culture solution, mixing, and 5% CO at 37 deg.C2Culturing under the condition.
3) Preparation of LPS culture solution
Taking 1mg LPS, adding 1mL sterile PBS to prepare a mother solution with the concentration of 1mg/mL, filtering and sterilizing by using a 0.22 mu m filter, and storing in a refrigerator at 4 ℃; for the experiment, DMEM complete medium was used to dilute the medium to 10. mu.g/mL.
Determination of cell Activity by MTT method
1) Collecting cells in logarithmic phase, adjusting the concentration of cell suspension, and dividing the cells into 96-well plates with each well having 180 mu L (the serum concentration of fresh culture solution used in the MTT method is 5%);
2) placing at 37 ℃ and 5% CO2Culturing in an incubator to make the cells adhere to the wall, and culturing for 24 hours;
3) discarding the old culture solution, adding only 180 μ L of fresh culture solution into the normal group (i.e. negative control group), adding fresh culture solution containing 10 μ g/mL LPS into the experimental group 1, adding LPS containing 10 μ g/mL and organic lentinan solution containing 50 μ g/mL into the experimental group 2, and continuing to culture for 24 h; each group has 3 multiple holes;
4) carefully removing the supernatant, adding 90 mu L of fresh culture solution, adding 10 mu L of MTT solution, and continuing to culture for 4 h; 5) absorbing the supernatant, adding 110 mu L of Formazan dissolving solution into each hole, placing on a shaking table, oscillating at low speed for 10min to fully dissolve the crystal, and measuring the light absorption value of each hole at 490nm of an enzyme-linked immunosorbent assay (ELISA) detector;
6) while setting zero setting hole (culture solution, MTT, Formazan solution)
Cell viability ═ (OD value of experimental cells/OD value of negative control group) × 100%.
4. Statistical analysis
The experimental data were analyzed using GraphPad prism7.0, with a p <0.05 considered significantly different between the two groups by unpaired t-test, and the experimental results are expressed as mean ± standard deviation.
5. Results of the experiment
5.1 cell survival
TABLE 1 Effect of lentinan on the survival of A549 cells by LPS action
According to the experimental result, the survival rate of the A549 cells after the LPS action is obviously lower than that of the normal group, and compared with the LPS action group, the survival rate of the A549 cells can be obviously increased after 50 mu g/mL lentinan is added, which shows that the lentinan has a protective effect on the A549 cells induced by the LPS (figure 1). As can be seen from FIG. 2, the cell growth status of the experimental group added with lentinan after stimulation by LPS is obviously superior to that of the unperfumed lentinan group, which shows that lentinan has a protective effect on A549 cells induced by LPS. Therefore, it can be shown that lentinan has the effect of enhancing cell activity.
Example 1
The preparation method of the lentinan soluble bean 1 for improving the intestinal immunity of children by diet comprises the following steps:
1) the organic lentinan solution is prepared by the following steps:
a. preparing an organic lentinan crude product:
cleaning well-grown and non-moldy organic mushroom fruiting body, cutting off root, dicing pileus, drying at 70-80 deg.C, grinding into powder,
② carrying out enzymolysis on the powder for 45min by cellulase (the concentration of the cellulase is 0.5 wt%) under the conditions of 45 ℃ and pH 4.6; adding papain (the concentration of papain is 1.5 wt%), and performing enzymolysis at 50 deg.C and pH of 6.1 for 30 min; adding choline chloride-1, 4-butanediol deep eutectic solvent (choline chloride and 1, 4-butanediol are mixed according to a molar ratio of 1: 4), extracting, filtering, dialyzing the obtained filtrate to remove impurities, carrying out microfiltration activated carbon adsorption and decoloration, and heating and concentrating; finally adding ethanol, stirring, standing, centrifuging, and drying the obtained precipitate at 50-60 deg.C to obtain lentinan crude product;
b. preparing an organic lentinan solution:
b, adding 50mL of water into each 20-30g of the lentinan crude product obtained in the step a to dissolve uniformly, and filtering to obtain an organic lentinan solution for later use;
2) the compound vitamin is prepared by the following steps:
weighing vitamin A and vitamin C at a weight ratio of 1:100 (the raw materials are converted into effective substances by adopting other varieties approved by GB 14880), adding into a nonmetal mortar, uniformly grinding for 1-2 minutes, and sealing for later use;
3) weighing the following components in parts by weight: 20 parts of organic lentinan solution, 5 parts of trehalose, 110 parts of skimmed milk powder, 15 parts of whey powder, 25 parts of wheat starch, 10 parts of egg yolk powder, 1 part of baking powder, 1 part of composite probiotics, 0.5 part of composite vitamin and 6 parts of organic honey; the fermentation powder consists of lactic acid bacteria and yeast extract in a weight ratio of 1: 1; the composite probiotics comprise lactobacillus bulgaricus, bifidobacterium lactis and streptococcus thermophilus; the weight ratio of the components is 1:100: 100;
4) dissolving: dissolving trehalose, skimmed milk powder, whey powder, grain starch, yolk powder and baking powder in sequence to obtain a mixed solution;
5) preheating: heating the mixed solution to 60-80 ℃ for preheating, and then filtering;
6) homogenizing: homogenizing the preheated filtrate at 70 ℃ under 20 MPa;
7) and (3) sterilization: heating and sterilizing the homogenized filtrate at 90-95 deg.C for 5-10 min;
8) inoculation: after sterilization, cooling to 45 ℃, and adding fermentation powder;
9) fermentation: fermenting the inoculated semi-finished product at 40 deg.C for 10 hr. Taking out when the acidity reaches 70 ℃ T, placing the mixture into a heat-preservation container to 4 ℃, and refrigerating;
10) mixing and emulsifying: stirring and demulsifying fermented and aged yoghourt, adding the organic lentinan solution, the composite probiotics, the composite vitamins and the organic honey, and uniformly stirring for later use;
11) freezing: pouring the obtained uniform material into a freezing machine for freezing treatment to obtain a semi-solid product for molding;
12) quick freezing: pouring the frozen material into a mould, and quickly freezing and molding for 1-2h at the temperature of-80 ℃;
13) and (3) freeze drying: placing the frozen yogurt into a stainless steel plate one by one, placing the yogurt into a cabin of a freeze dryer, and freeze-drying to obtain dry solid soluble beans;
14) weighing the obtained dry solid dissolved beans, and subpackaging to obtain the organic lentinan dissolved beans 1.
Example 2
The preparation method of the lentinan soluble bean 2 for improving the intestinal immunity of children by diet comprises the following steps:
1) the organic lentinan solution is prepared by the following steps:
a. preparing an organic lentinan crude product:
cleaning well-grown and non-moldy organic mushroom fruiting body, cutting off root, dicing pileus, drying at 70-80 deg.C, grinding into powder,
② enzymolysis is carried out on the cellulase (the concentration of the cellulase is 0.5 wt%, the aqueous solution) in the powder for 45min under the conditions that the temperature is 45 ℃ and the pH value is 4.6; adding papain (papain concentration of 1.5 wt%, water solution), and performing enzymolysis at 50 deg.C and pH of 6.1 for 30 min; adding choline chloride-1, 4-butanediol deep eutectic solvent (choline chloride and 1, 4-butanediol are mixed according to a molar ratio of 1: 4), extracting, filtering, dialyzing the obtained filtrate to remove impurities, carrying out microfiltration activated carbon adsorption and decoloration, and heating and concentrating; finally adding ethanol, stirring, standing, centrifuging, and drying the obtained precipitate at 50-60 deg.C to obtain lentinan crude product;
b. preparing an organic lentinan solution:
b, adding 50mL of water into each 20-30g of the lentinan crude product obtained in the step a to dissolve uniformly, and filtering to obtain an organic lentinan solution for later use;
2) the compound vitamin is prepared by the following steps:
taking vitamin A and vitamin C (the raw materials are converted into effective substances by adopting other varieties approved by GB 14880) according to the weight ratio of 1:100, adding into a nonmetal mortar, uniformly grinding for 1-2 minutes, and sealing for later use;
3) weighing the following components in parts by weight: 18 parts of organic lentinan solution, 6 parts of trehalose, 115 parts of skimmed milk powder, 18 parts of whey powder, 26 parts of wheat starch, 20 parts of egg yolk powder, 2 parts of baking powder, 2 parts of composite probiotics, 0.6 part of composite vitamin and 7 parts of organic honey; the fermentation powder consists of lactic acid bacteria and yeast extract in a weight ratio of 1: 1; the composite probiotics comprise lactobacillus bulgaricus, bifidobacterium lactis and streptococcus thermophilus; the weight ratio of the components is 1:100: 100;
4) dissolving: dissolving trehalose, skimmed milk powder, whey powder, grain starch, yolk powder and baking powder in sequence to obtain a mixed solution;
5) preheating: heating the mixed solution to 60-80 ℃ for preheating, and then filtering;
6) homogenizing: homogenizing the preheated filtrate at 70 ℃ under 20 MPa;
7) and (3) sterilization: heating and sterilizing the homogenized filtrate at 90-95 deg.C for 5-10 min;
8) inoculation: after sterilization, cooling to 45 ℃, and adding fermentation powder;
9) fermentation: fermenting the inoculated semi-finished product at 40 deg.C for 10 hr. Taking out when the acidity reaches 70 ℃ T, placing the mixture into a heat-preservation container to 4 ℃, and refrigerating;
10) mixing and emulsifying: stirring and demulsifying fermented and aged yoghourt, adding the organic lentinan solution, the composite probiotics, the composite vitamins and the organic honey, and uniformly stirring for later use;
11) freezing: pouring the obtained uniform material into a freezing machine for freezing treatment to obtain a semi-solid product for molding;
12) quick freezing: pouring the frozen material into a mould, and quickly freezing and molding for 1-2h at the temperature of-80 ℃;
13) and (3) freeze drying: placing the frozen yogurt into a stainless steel plate one by one, placing the yogurt into a cabin of a freeze dryer, and freeze-drying to obtain dry solid soluble beans;
14) weighing the obtained dry solid dissolved beans, and subpackaging to obtain the organic lentinan dissolved beans 2.
Example 3
The preparation method of the lentinan soluble bean 3 for improving the intestinal immunity of children by diet comprises the following steps:
1) the organic lentinan solution is prepared by the following steps:
a. preparing an organic lentinan crude product:
cleaning well-grown and non-moldy organic mushroom fruiting body, cutting off root, dicing pileus, drying at 75 deg.C, grinding into powder,
② enzymolysis is carried out on the cellulase (the concentration of the cellulase is 0.5 wt%, the aqueous solution) in the powder for 45min under the conditions that the temperature is 45 ℃ and the pH value is 4.6; adding papain (papain concentration of 1.5 wt%, water solution), and performing enzymolysis at 50 deg.C and pH of 6.1 for 30 min; adding choline chloride-1, 4-butanediol deep eutectic solvent (choline chloride and 1, 4-butanediol are mixed according to a molar ratio of 1: 4), extracting, filtering, dialyzing the obtained filtrate to remove impurities, carrying out microfiltration activated carbon adsorption and decoloration, and heating and concentrating; finally adding ethanol, stirring, standing, centrifuging, and drying the obtained precipitate at 55 deg.C to obtain lentinan crude product;
b. preparing an organic lentinan solution:
b, adding 50mL of water into each 20-30g of the lentinan crude product obtained in the step a to dissolve uniformly, and filtering to obtain an organic lentinan solution for later use;
2) the compound vitamin is prepared by the following steps:
weighing vitamin A and vitamin C at a weight ratio of 1:100 (the raw materials are converted into effective substances by adopting other varieties approved by GB 14880), adding into a nonmetal mortar, uniformly grinding for 1-2 minutes, and sealing for later use;
3) weighing the following components in parts by weight: 30 parts of organic lentinan solution, 7 parts of trehalose, 120 parts of skimmed milk powder, 17 parts of whey powder, 27 parts of wheat starch, 30 parts of egg yolk powder, 3 parts of baking powder, 3 parts of composite probiotics, 0.7 part of composite vitamin and 8 parts of organic honey; the fermentation powder consists of lactic acid bacteria and yeast extract in a weight ratio of 1: 1; the composite probiotics comprise lactobacillus bulgaricus, bifidobacterium lactis and streptococcus thermophilus; the weight ratio of the components is 1:100: 100;
4) dissolving: dissolving trehalose, skimmed milk powder, whey powder, grain starch, yolk powder and baking powder in sequence to obtain a mixed solution;
5) preheating: heating the mixed solution to 60-80 ℃ for preheating, and then filtering;
6) homogenizing: homogenizing the preheated filtrate at 70 ℃ under 20 MPa;
7) and (3) sterilization: heating and sterilizing the homogenized filtrate at 90-95 deg.C for 5-10 min;
8) inoculation: after sterilization, cooling to 45 ℃, and adding fermentation powder;
9) fermentation: fermenting the inoculated semi-finished product at 40 deg.C for 10 hr. Taking out when the acidity reaches 70 ℃ T, placing the mixture into a heat-preservation container to 4 ℃, and refrigerating;
10) mixing and emulsifying: stirring and demulsifying fermented and aged yoghourt, adding the organic lentinan solution, the composite probiotics, the composite vitamins and the organic honey, and uniformly stirring for later use;
11) freezing: pouring the obtained uniform material into a freezing machine for freezing treatment to obtain a semi-solid product for molding;
12) quick freezing: pouring the frozen material into a mould, and quickly freezing and molding for 1-2h at the temperature of-80 ℃;
13) and (3) freeze drying: placing the frozen yogurt into a stainless steel plate one by one, placing the yogurt into a cabin of a freeze dryer, and freeze-drying to obtain dry solid soluble beans;
14) weighing the obtained dry solid dissolved beans, and subpackaging to obtain the organic lentinan dissolved beans 3.
Example 4
The method for preparing the organic lentinan soluble bean 4 in the embodiment is basically the same as the method for preparing the organic lentinan soluble bean 2 in the embodiment, and the difference is that:
the raw materials of the organic lentinan soluble bean 4 comprise 15 parts of organic lentinan solution, 8 parts of trehalose, 110 parts of skimmed milk powder, 10 parts of whey powder, 28 parts of wheat starch, 20 parts of egg yolk powder, 4 parts of baking powder, 4 parts of composite probiotics, 0.8 part of composite vitamins and 9 parts of organic honey according to the weight part ratio, wherein the baking powder consists of lactic acid bacteria and yeast extract, and the weight ratio is 1: 1.
The composite probiotics comprise lactobacillus bulgaricus, bifidobacterium lactis and streptococcus thermophilus; the weight ratio of the components is 1:100: 100;
the compound vitamin comprises vitamin A and vitamin C at a weight ratio of 1:100
Example 5
The method for preparing the organic lentinan soluble bean 5 in the embodiment is basically the same as the method for preparing the organic lentinan soluble bean 2 in the embodiment, and the difference is that:
the raw materials of the organic lentinan soluble bean 5 comprise, by weight, 38 parts of an organic lentinan solution, 9 parts of trehalose, 120 parts of skimmed milk powder, 16 parts of whey powder, 29 parts of cereal starch, 50 parts of egg yolk powder, 5 parts of baking powder, 5 parts of composite probiotics, 1 part of composite vitamins and 10 parts of organic honey; wherein the fermentation powder consists of lactobacillus and yeast extract with the weight ratio of 1: 1.
The composite probiotics comprise lactobacillus bulgaricus, bifidobacterium lactis and streptococcus thermophilus; the weight ratio of the components is 1:100: 100;
the compound vitamin consists of vitamin A and vitamin C in a weight ratio of 1: 100.
Among them, the most preferable example is example 3. In example 3, the contents of lentinan and skimmed milk powder are high, and the contents of trehalose, baking powder, wheat starch and the like are moderate. Therefore, example 3 has suitable sweetness, higher immunocompetence and balanced nutrients.
Other parts not described in detail are prior art. Although the present invention has been described in detail with reference to the above embodiments, it is only a part of the embodiments of the present invention, not all of the embodiments, and other embodiments can be obtained without inventive step according to the embodiments, and the embodiments are within the scope of the present invention.
Claims (10)
1. A lentinan soluble bean for improving intestinal immunity of children by diet is characterized in that: the raw materials of the compound mushroom health-care food comprise, by weight, 10-40 parts of an organic lentinan solution, 5-10 parts of trehalose, 120 parts of skimmed milk powder, 10-20 parts of whey powder, 25-30 parts of cereal starch, 10-50 parts of egg yolk powder, 1-5 parts of fermentation powder, 1-5 parts of compound probiotics, 0.5-1 part of compound vitamins and 5-10 parts of organic honey.
2. The lentinan soluble bean for improving the intestinal immunity of children according to the diet of claim 1, which is characterized in that: the raw materials of the compound mushroom health-care food comprise, by weight, 20-30 parts of an organic lentinan solution, 6-9 parts of trehalose, 110 parts of skimmed milk powder, 10-15 parts of whey powder, 25-30 parts of cereal starch, 20-40 parts of egg yolk powder, 1-3 parts of baking powder, 1-3 parts of compound probiotics, 0.5-1 part of compound vitamins and 5-8 parts of organic honey.
3. The lentinan soluble bean for dietary improvement of intestinal immunity of children according to claim 1 or 2, characterized in that: the cereal starch is wheat starch or rice starch;
the fermentation powder consists of lactic acid bacteria and yeast extract in a weight ratio of 1: 1-2.
4. The lentinan soluble bean for dietary improvement of intestinal immunity of children according to claim 1 or 2, characterized in that: the composite probiotics comprise lactobacillus bulgaricus, bifidobacterium lactis and streptococcus thermophilus; the weight ratio of the components is 1:100: 100;
the compound vitamin consists of vitamin A and vitamin C in the weight ratio of 1: 20-600.
5. The lentinan soluble bean for dietary improvement of intestinal immunity of children according to claim 1 or 2, characterized in that: the raw materials of the compound mushroom health-care product comprise, by weight, 30 parts of an organic lentinan solution, 7 parts of trehalose, 120 parts of skimmed milk powder, 17 parts of whey powder, 27 parts of wheat starch, 30 parts of yolk powder, 3 parts of baking powder, 3 parts of compound probiotics, 0.7 part of compound vitamin and 8 parts of organic honey; the fermentation powder consists of lactic acid bacteria and yeast extract in a weight ratio of 1: 1; the composite probiotics comprise lactobacillus bulgaricus, bifidobacterium lactis and streptococcus thermophilus; the weight ratio of the components is 1:100: 100; the compound vitamin consists of vitamin A and vitamin C according to the weight ratio of 1: 100.
6. The lentinan soluble bean for dietary improvement of intestinal immunity of children according to claim 1 or 2, characterized in that: the shape of the lentinan soluble bean is selected from heart shape, spherical shape and strawberry shape.
7. A method for preparing lentinan soluble bean for improving the intestinal immunity of children by diet as claimed in claim 1, which is characterized in that: the method comprises the following steps:
1) weighing the following components in parts by weight: 10-40 parts of organic lentinan solution, 5-10 parts of trehalose, 120 parts of skimmed milk powder, 10-20 parts of whey powder, 25-30 parts of cereal starch, 10-50 parts of yolk powder, 1-5 parts of fermentation powder, 1-5 parts of composite probiotics, 0.5-1 part of composite vitamins and 5-10 parts of organic honey;
2) dissolving: dissolving trehalose, skimmed milk powder, whey powder, grain starch, yolk powder and baking powder in sequence to obtain a mixed solution;
3) preheating: heating the mixed solution to 60-80 ℃ for preheating, and then filtering;
4) homogenizing: homogenizing the preheated filtrate;
5) and (3) sterilization: heating and sterilizing the homogenized filtrate at 90-95 deg.C for 5-10 min;
6) inoculation: after sterilization, cooling to 45 ℃, and adding fermentation powder;
7) fermentation: fermenting the inoculated semi-finished product at 40 deg.C for 10 hr. Taking out when the acidity reaches 70 ℃ T, placing the mixture into a heat-preservation container to 4 ℃, and refrigerating;
8) mixing and emulsifying: stirring and demulsifying fermented and aged yoghourt, adding the organic lentinan solution, the composite probiotics, the composite vitamins and the organic honey, and uniformly stirring for later use;
9) freezing: pouring the obtained uniform material into a freezing machine for freezing treatment to obtain a semi-solid product for molding;
10) quick freezing: pouring the frozen material into a mould, and quickly freezing and molding for 1-2h at the temperature of-80 ℃;
11) and (3) freeze drying: placing the frozen yogurt into a stainless steel plate one by one, placing the yogurt into a cabin of a freeze dryer, and freeze-drying to obtain dry solid soluble beans;
12) weighing the obtained dry solid dissolved beans, and subpackaging to obtain the organic lentinan dissolved beans.
8. The method for preparing lentinan soluble bean for improving the intestinal immunity of children according to claim 7, which is characterized by comprising the following steps: in the step 1) described above, the step of,
the organic lentinan solution is prepared by the following steps:
a. preparing an organic lentinan crude product:
cleaning fruiting body of organic Lentinus Edodes which grows well and does not go moldy, cutting off root, dicing pileus, oven drying at 70-80 deg.C, grinding into powder, adding cellulase and papain for enzymolysis, adding choline chloride-1, 4-butanediol deep eutectic solvent for extraction, filtering, dialyzing the filtrate to remove impurities, adsorbing with microfiltration active carbon for decolorizing, and heating for concentration; finally adding ethanol, stirring, standing, centrifuging, and drying the obtained precipitate at 50-60 deg.C to obtain lentinan crude product;
b. preparing an organic lentinan solution:
c, adding water to the organic lentinan crude product obtained in the step a for uniform dissolution, and filtering to obtain an organic lentinan solution for later use;
the compound vitamin is prepared by the following steps:
weighing vitamin A and vitamin C according to the weight ratio of 1:20-600, adding into a nonmetal mortar, uniformly grinding for 1-2 minutes, and sealing for later use.
The fermentation powder consists of lactobacillus and yeast extract in the weight ratio of 1 to 1-2.
The composite probiotics comprise lactobacillus bulgaricus, bifidobacterium lactis and streptococcus thermophilus; their weight ratio was 1:100: 100.
9. The method for preparing lentinan soluble bean for improving the intestinal immunity of children according to claim 8, which is characterized by comprising the following steps: in the step a, the step (c) is carried out,
the choline chloride-1, 4-butanediol deep eutectic solvent is formed by mixing choline chloride and 1, 4-butanediol, wherein the molar ratio of the choline chloride to the 1, 4-butanediol is 1: 4;
the enzymolysis conditions of the cellulase are as follows:
performing enzymolysis at 45 deg.C and pH of 4.6 for 45 min;
the enzymolysis conditions of the papain are as follows:
performing enzymolysis at 50 deg.C and pH of 6.1 for 30 min;
the concentration of the cellulase is 0.5wt percent, and the concentration of the papain is 1.5wt percent;
the ethanol is 95% ethanol solution by volume concentration.
10. The method for preparing lentinan soluble bean according to claim 8, wherein the lentinan soluble bean comprises the following steps: in the step b, 50mL of water is added into each 20-30g of lentinan crude product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011392950.5A CN112544712A (en) | 2020-12-01 | 2020-12-01 | Lentinan soluble bean for improving intestinal immunity of children by diet and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011392950.5A CN112544712A (en) | 2020-12-01 | 2020-12-01 | Lentinan soluble bean for improving intestinal immunity of children by diet and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112544712A true CN112544712A (en) | 2021-03-26 |
Family
ID=75047250
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011392950.5A Pending CN112544712A (en) | 2020-12-01 | 2020-12-01 | Lentinan soluble bean for improving intestinal immunity of children by diet and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112544712A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115624067A (en) * | 2022-10-21 | 2023-01-20 | 武汉轻工大学 | Organic selenium-rich lentinus edodes polypeptide soluble bean and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103651802A (en) * | 2013-12-04 | 2014-03-26 | 佛山市新战略知识产权文化有限公司 | Formula of healthcare yoghourt |
CN108503719A (en) * | 2018-03-05 | 2018-09-07 | 华南理工大学 | A method of extraction Dendrobium officinale polysaccharide |
CN110074185A (en) * | 2019-04-17 | 2019-08-02 | 湖北工业大学 | Phycocyanin steamed dumpling with pork, mushrooms and bamboo shoots vegetable solid-state yoghourt product and its processing method |
CN110169547A (en) * | 2019-06-21 | 2019-08-27 | 福建利众诚食品有限公司 | Molten beans of a kind of freeze-drying egg and preparation method thereof |
CN110859220A (en) * | 2019-11-29 | 2020-03-06 | 湖北工业大学 | Yoghourt dissolving bean rich in yeast β -glucan and amino acid and preparation method thereof |
-
2020
- 2020-12-01 CN CN202011392950.5A patent/CN112544712A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103651802A (en) * | 2013-12-04 | 2014-03-26 | 佛山市新战略知识产权文化有限公司 | Formula of healthcare yoghourt |
CN108503719A (en) * | 2018-03-05 | 2018-09-07 | 华南理工大学 | A method of extraction Dendrobium officinale polysaccharide |
CN110074185A (en) * | 2019-04-17 | 2019-08-02 | 湖北工业大学 | Phycocyanin steamed dumpling with pork, mushrooms and bamboo shoots vegetable solid-state yoghourt product and its processing method |
CN110169547A (en) * | 2019-06-21 | 2019-08-27 | 福建利众诚食品有限公司 | Molten beans of a kind of freeze-drying egg and preparation method thereof |
CN110859220A (en) * | 2019-11-29 | 2020-03-06 | 湖北工业大学 | Yoghourt dissolving bean rich in yeast β -glucan and amino acid and preparation method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115624067A (en) * | 2022-10-21 | 2023-01-20 | 武汉轻工大学 | Organic selenium-rich lentinus edodes polypeptide soluble bean and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105146614B (en) | A kind of functional calcium fruit ferment, enzyme beverage and its production method | |
CN108812909B (en) | Complementary food nutritional supplement for improving monophagia or anorexia and preparation method thereof | |
CN105167072B (en) | A kind of production method of feature matrimony vine ferment and its product | |
CN104814502B (en) | A kind of probiotics cereal beverage and pulvis and preparation method thereof | |
CN111990461A (en) | Mixed milk powder for enhancing immunity and preparation method thereof | |
CN105962378A (en) | Preparation method of active lactobacillus preparation containing hericium polysaccharides | |
CN108795823B (en) | It is a kind of improve women pregnant and lying-in women's intestinal flora probiotics cultural method and application | |
CN112544712A (en) | Lentinan soluble bean for improving intestinal immunity of children by diet and preparation method thereof | |
JP2018070570A (en) | Lindera plant extract | |
CN116076728B (en) | Composition for promoting growth of bifidobacteria | |
CN111436597B (en) | Lipotide and its production process | |
CN107712879A (en) | A kind of preparation method of low sugar activity matrimony vine ferment | |
CN112425655A (en) | Formula milk powder for preventing hyperlipidemia, hyperglycemia and hypertension and preparation method thereof | |
CN110101076B (en) | Production method of burdock enzyme rich in flavonoid aglycone and active probiotics | |
CN112450441A (en) | Organic lentinan soluble bean for improving intestinal immunity and preparation method thereof | |
CN109938276A (en) | A kind of day shellfish compound formulation improving spacefarer's constitution | |
CN105533627B (en) | A kind of method that bamboo shoot process residue prepares solid-state ferment flavouring | |
CN112704234A (en) | Nutritional composition containing composite peptide and probiotics and preparation method thereof | |
CN114304651A (en) | Composition for improving immunity | |
CN113068824A (en) | High-protein composite nutritional coarse cereal edible fungus powder food and preparation method thereof | |
CN113693109B (en) | Corn cookie biscuit and preparation method thereof | |
CN110547446A (en) | royal jelly antioxidant peptide fruit enzyme and preparation method thereof | |
CN107410798A (en) | It is a kind of that there is herb fermenting beverage for improving efficacy of immunity and preparation method thereof | |
CN110754662B (en) | Yellow blood silkworm cordyceps militaris chicken essence electuary suitable for people prone to fatigue and preparation method thereof | |
CN106063503A (en) | Metallothionein rich selenium germanium yoghurt product technique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210326 |
|
RJ01 | Rejection of invention patent application after publication |